Zurueck zur Suche

Reporte zur Charge UJ933AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

16Reporte angezeigt
0Todesfaelle
3Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 5 MI 2 OH 2 UT 1 NJ 1 TX 1 CT 1 MN 1

VAERS 2530029

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge uj933aa

kritisch
Staat
-
Alter
89,0
Geschlecht
F
Eingang
13.12.2022
Impfdatum
18.10.2022
Beginn
11.12.2022
Tage bis Beginn
54,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Alanine aminotransferase normal Anaemia Anion gap Anticoagulant therapy Aspartate aminotransferase normal Asthenia Bacterial test Base excess Basophil count decreased Basophil percentage decreased Bilirubin urine Blood albumin normal Blood alkaline phosphatase normal Blood bicarbonate Blood bilirubin normal Blood calcium decreased Blood chloride normal Blood creatinine increased

Symptomtext

Document Type: History and Physical Document Subject: History & Physical Note Performed By: DO on December 12, 2022 05:10 Verified By: DO on December 12, 2022 05:10 Encounter Info: Hospital, Observation, 12/11/22 - * Final Report * Chief Complaint cough History of Present Illness/Subjective Patient presents via private vehicle due to fatigue, generalized weakness, productive cough, DOE and low grade fever x 4 days. Patient was seen at Clinic on Thursday and diagnosed with bronchitis. She was started on amoxicillin and prednisone at that time. She was negative for Covid and flu at that time. Patient denies chest pain, n/v/d . Associated medical hx includes: Add'l medical hx includes: HTN, HLD, OA, MDD, neuropathy, Social hx: lives at home alone, non smoker CXR shows right sided infiltrate concerning for pneumonia. Patient is also Covid +. She is Covid vaccinated. Flu is negative. No leukocytosis, not septic. Not hypoxic at rest. Discussed discharge to home with antibiotic change to Augmentin and doxy with patient and her daughter to better cover for pneumonia. Also, advised to stop prednisone. Patient and her daughter are not comfortable with discharge at this time due to patient's general weakness since being ill. She lives at home alone, no one can stay with her. Review of Systems A complete, 13-system review was performed and was negative except for as noted in the HPI. Physical Exam/Objective Vital Signs (most recent and range for last 24 hours) Temp (CEL) 36.5 (36.5-36.5) Temp (FAHR) 97.7 (97.7-97.7), BP 167/70 (144-212)/(65-89), HR 53 (53-83), RR 16 (16-18), O2Sat 94 (94-94) Neurologic (most recent and range for last 24 hours) GCS 15(15-15) Patient Weight Current Daily Weight: 95 kg 12/11/22 Patient Height Current Height: 152.79 cm 12/11/22 Constitutional: No acute distress, well-nourished Eyes: PERRL, EOMI, normal conjunctiva, no scleral icterus ENMT: Moist oral mucosa Neck: Supple, non-tender, intact range of motion Respiratory: Lungs are coarse, scattered rhonchi, Respirations are labored, RLL Crackles, no wheezes Cardiovascular: Regular rate and rhythm Gastrointestinal: Soft, non-tender, non-distended Musculoskeletal: No joint swelling, no deformity, intact ROM Integumentary: Intact, warm, dry no rashes Neurologic: Alert & Oriented x 3, no cognitive impairment, no focal deficits Psychiatric: Cooperative, appropriate mood and affect, denies SI or HI Assessment/Plan 1. Weakness R53.1 Will place in observation and have PT OT eval's to make sure it is safe for patient to go home since she lives alone Likely due to #2 and #3, no focal deficits suggesting CVA or neurologic process 2. Pneumonia J18.9 Will cover for CAP with Rocephin Doxy, collect sputum cultures, Legionella, strep antigen, and continue to monitor 3. COVID-19 U07.1 At present time disease appears to be mild, will start fluticasone inhalation, respiratory assessment, collect inflammatory markers, start famotidine, and continue to monitor, supplemental O2 as needed 4. Anemia D64.9 Noted. Stable, no evidence of acute bleeding, maintain hemoglobin greater than 7 5. HTN (hypertension) I10 6. Hyperlipidemia E78.5 7. OA (osteoarthritis) M19.90 8. Major depression F32.9 9. Neuropathy G62.9 Noted. Continue home medications as appropriate 10. DVT prophylaxis Z29.9 Lovenox subcu and SCDs while in bed Code Status None Recorded Chronic Problem List Anxiety Arthritis Chronic right sacroiliac pain Cystitis cystica DDD (degenerative disc disease), lumbar Depression Essential hypertension Headache History of kidney stones Hyperlipidemia Hypothyroid Idiopathic neuropathy Kidney cysts Leg cramps Lichenoid drug reaction Limb pain LVH (left ventricular hypertrophy) Major depression Morbid obesity OA (osteoarthritis) OG (onychogryphosis) OM (onychomycosis) Onychomycosis of toenail Osteoporosis Peripheral neuropathy, hereditary/idiopathic Recurrent UTI Right hip pain Tremor Vertigo Procedure/Surgical History ?Diabetic retinal eye exam (08/09/2021) ?Eye examination (02/25/2019) ?Repair of bladder (2009) ?Total hysterectomy (2009) ?Cataract surgery ?Tonsillectomy Medications Home Medications (23) Active amoxicillin 500 mg oral capsule 500 mg = 1 Capsule, Orally, TID aspirin 81 mg oral tablet 81 mg = 1 Tablet, Orally, Daily Ativan 0.5 mg oral tablet 0.5 mg = 1 Tablet, PRN, Orally, TID carvedilol 6.25 mg oral tablet 6.25 mg = 1 Tablet, Orally, BID cholestyramine 4 g/5 g oral powder for reconstitution 4 GM, Orally, BID cranberry oral tablet doxazosin 2 mg oral tablet 2 mg = 1 Tablet, Orally, BID Estrace Vaginal Cream 0.1 mg/gm 1 GM, Vaginally, 2x/WK, Apply pea sized amount to outside vaginal area nightly before bed x 2 weeks then 2x/week thereafter. levothyroxine 50 mCg (0.05 mg) oral tablet 75 mCg = 1.5 Tablet, Orally, Daily Lexapro 20 mg oral tablet 20 mg = 1 Tablet, Orally, Daily losartan 100 mg oral tablet 100 mg = 1 Tablet, Orally, Daily Misc Med , D-Mannose1 pill BIDOTC Nexium 40 mg oral delayed release capsule 40 mg = 1 Capsule, Orally, Daily predniSONE 10 mg oral tablet See Instructions, 5 tab orally today, then 4 tab x 3 days, then 3 tab x 3 days, then 2 tab x 3 days, then 1 tab x 3 days ProAir HFA 90 mCg/inh inhalation aerosol 2 Puff, PRN, Inhalation, Q4H Sarna 0.5%-0.5% topical lotion See Instructions, PRN, Topical TID spironolactone 25 mg oral tablet 25 mg = 1 Tablet, Orally, BID Systane Ultra preserved ophthalmic solution 1 Drop Tessalon Perles 100 mg oral capsule 100 mg = 1 Capsule, Orally, TID Vitamin C 1,000 mg, Orally, Daily Vitamin D3 (cholecalciferol) , Orally Voltaren Topical 1% topical gel 2 GM, Topical, 4 Times Daily, Use dosing card to measure dose Zofran ODT 4 mg oral tablet, disintegrating 4 mg = 1 Tablet, PRN, Orally, Q6H Active Scheduled Inpatient Medications None Reported One-Time Medications Given 12/11/22 00:00:00 TO 12/12/22 05:10:16 benzonatate (Tessalon Perles), Capsule, 200 mg, Orally, ONCE, (1 DOSE 12/12/22 01:25:00) ceftRIAXone, Injection, 2 GM, IVPB, ONCE, (1 DOSE 12/11/22 21:07:00) doxycycline, Injection, 100 mg, IVPB, ONCE, (1 DOSE 12/11/22 21:55:00) guaiFENesin (Mucinex 600 mg oral tablet, extended release), Tab, Extended Rel, 600 mg, Orally, ONCE, (1 DOSE 12/12/22 01:40:00) hydroCODONE-acetaminophen (hydroCODONE-acetaminophen 5 mg-325 mg oral tablet), Tablet, 1 Tablet, Orally, ONCE, (1 DOSE 12/11/22 22:19:00) PRN Medications (0600 - 0559) from 12/11 - 12/12 None Reported Allergies Dyazide (Unknown) Sular (Flushing) Yellow Dye (Sores in mouth, Unknown) Zocor (Unknown) sulfa drugs (Rash) Social History Alcohol Denies Electronic Cigarette/Vaping E-Cigarette Use Never. Home/Environment Widow- 3 children, Lives with Alone. Substance Abuse Denies Tobacco Tobacco Use: Never (less than 100 in lifetime). Family History Congestive heart failure..: Father. Diabetes mellitus type 2: Grandmother. Diabetes...: Brother. Emphysema: Father. Heart disease..: Father. Hypertension..: Mother. Osteoarthritis: Mother. Uterine cancer: Mother. Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 6.3 k/cumm (12/11/22 20:18:00) RBC: 3.42 million/cumm Low (12/11/22 20:18:00) Hgb: 11 GM/dL Low (12/11/22 20:18:00) Hct: 32.7 % Low (12/11/22 20:18:00) MCV: 96 fL (12/11/22 20:18:00) MCH: 32.1 pg (12/11/22 20:18:00) MCHC: 33.5 GM/dL (12/11/22 20:18:00) RDW: 12.8 % (12/11/22 20:18:00) Platelet: 250 k/cumm (12/11/22 20:18:00) MPV: 7.8 fL (12/11/22 20:18:00) Neutrophils %: 83 % (12/11/22 20:18:00) Lymphocytes %: 7 % (12/11/22 20:18:00) Monocytes %: 10 % (12/11/22 20:18:00) Eosinophils %: 0 % (12/11/22 20:18:00) Basophils %: 0 % (12/11/22 20:18:00) Absolute Neutrophil: 5.2 k/cumm (12/11/22 20:18:00) Absolute Lymphocyte: 0.4 k/cumm Low (12/11/22 20:18:00) Absolute Monocyte: 0.6 k/cumm (12/11/22 20:18:00) Absolute Eosinophil: 0 k/cumm (12/11/22 20:18:00) Absolute Basophil: 0 k/cumm (12/11/22 20:18:00) Chemistry: Sodium SerPl QN: 140 mmol/L (12/11/22 20:18:00) Potassium SerPl QN: 3.9 mmol/L (12/11/22 20:18:00) Chloride SerPl QN: 103 mmol/L (12/11/22 20:18:00) Carbon Dioxide SerPl QN: 26 mmol/L (12/11/22 20:18:00) Anion Gap: 11 mmol/L (12/11/22 20:18:00) BUN SerPl QN: 17 mg/dL (12/11/22 20:18:00) Creatinine SerPl QN: 1.14 mg/dL (12/11/22 20:18:00) Estimated GFR (CKD-EPI, no race): 46 mL/min/1.73m2 Low (12/11/22 20:18:00) Estimated CRCL (CG): 35 mL/min Low (12/11/22 20:18:00) Glucose SerPl QN: 129 mg/dL High (12/11/22 20:18:00) Calcium Total SerPl QN: 8.8 mg/dL (12/11/22 20:18:00) Alkaline Phos SerPl QN: 48 Units/L (12/11/22 20:18:00) ALT SerPl QN: 14 Units/L (12/11/22 20:18:00) AST SerPl QN: 17 Units/L (12/11/22 20:18:00) Bilirubin Total SerPl QN: 0.3 mg/dL (12/11/22 20:18:00) Total Protein SerPl QN: 6.2 GM/dL Low (12/11/22 20:18:00) Albumin SerPl QN: 3.7 GM/dL (12/11/22 20:18:00) Troponin-I High Sensitivity: 18 ng/L High (12/11/22 22:31:00) BNP Pl QN: 125 pg/mL High (12/11/22 20:18:00) Lactate Venous Pl QN: 1.3 mmol/L (12/11/22 20:18:00) Blood Gas Comment: venous (12/11/22 22:31:00) pH Bld Venous QN: 7.35 (12/11/22 22:31:00) PCO2 Bld Venous QN: 47 mmHg (12/11/22 22:31:00) PO2 Bld Venous QN: 46 mmHg High (12/11/22 22:31:00) Base Excess Bld Venous: 0 mmol/L (12/11/22 22:31:00) Bicarb Bld Venous Calc: 26 mmol/L (12/11/22 22:31:00) O2 Sat Bld Venous Calc: 79 % (12/11/22 22:31:00) Patient Temperature: 37 DegC (12/11/22 22:31:00) Urine Studies: Color: Yellow (12/11/22 22:17:00) Clarity: Clear (12/11/22 22:17:00) Specific Gravity: <=1.005 (12/11/22 22:17:00) pH: 6.5 (12/11/22 22:17:00) Protein: NEGATIVE (12/11/22 22:17:00) Glucose: NEGATIVE (12/11/22 22:17:00) Ketones: NEGATIVE (12/11/22 22:17:00) Bilirubin: NEGATIVE (12/11/22 22:17:00) Hgb Ur: NEGATIVE (12/11/22 22:17:00) Nitrite: NEGATIVE (12/11/22 22:17:00) Urobilinogen: NormalUro (12/11/22 22:17:00) Leukocyte Esterase Ur: NEGATIVE (12/11/22 22:17:00) All Other Labs: COVID 19 Specimen Source: Nasopharyngeal (12/11/22 20:18:00) Coronavirus SARS-CoV2 Rapid: Detected Abnormal (12/11/22 20:18:00) Micro - Last 7 days Rapid Influenza Method: PCR - Liat (12/11/22 20:18:00) Rapid Influenza A PCR: Not Detected (12/11/22 20:18:00) Rapid Influenza B PCR: Not Detected (12/11/22 20:18:00) Coronavirus SARS Ag FIA, POC: Negat (12/06/22 11:50:00) Diagnostics Radiology Results - Last 24 hours Across Visits 12/11/2022 20:04 - XR Chest PA or AP IMPRESSION:Focal right basilar airspace disease concerning for pneumoniaThank you for consulting our team of subspecialty radiologists at Radiology. Healthcare providers wishing to discussthis case further can contact the Cardiothoracic Reading Room. For after-hours or emergency department cases, pleasecall. Signature Line Electronically Signed on 12/12/22 05:10 ________________________________________________________ DO

Weitere VAERSDATA-Felder
Praegender Schweregrund
Coma scale
Hospital-Tage
-
Labordaten
Molecular Diagnostic Tests COVID 19 Specimen Source Nasopharyngeal Coronavirus SARS-CoV2 Rapid * (A) Detected Microbiology Studies - Bacterial Blood CX NEG In Progress; NEG In Progress Resp CX + Stn NEG In Progress Bacterial L pneumo Urine Ag QL Not Detected L pneumo Urine Ag QL Interp L pneumo Urine Ag QL Interp Strep pneumo Ag Ur Not Detected Strep pneumo Ag Ur Interp Negative Viral FS Rapid Influenza Method PCR - Liat Rapid Influenza A PCR * Not Detected Rapid Influenza B PCR * Not Detected
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2518384

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AA

schwer
Staat
UT
Alter
67,0
Geschlecht
F
Eingang
30.11.2022
Impfdatum
05.11.2022
Beginn
22.11.2022
Tage bis Beginn
17,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal X-ray Asthenia Central venous catheterisation Chest X-ray Computerised tomogram head Hypoaesthesia Hypoaesthesia oral Mobility decreased Sensory loss Electrocardiogram Endotracheal intubation Fall Immunoglobulin therapy Intensive care Laboratory test Lumbar puncture Magnetic resonance imaging spinal Muscular weakness

Symptomtext

Covid, Influenza and Zoster vaccines were all administered at Pharmacy on 11/5/2022. On 11/22/2022 patient came into the ER. Patient claimed she felt weak the day after the vaccines. with lost of all sensation and control over her legs. Patient was admitted in the ER and sent to the medical floor for observation. Numbness also spreads to her hands and the tip of her tongue. Patient received Neurology Consult and possible Guillain Barre Syndrome.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2627406

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AA

moderat
Staat
MI
Alter
68,0
Geschlecht
F
Eingang
05.05.2023
Impfdatum
19.10.2022
Beginn
24.03.2023
Tage bis Beginn
156,0
Dosis
N/A
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Anticoagulant therapy Blood creatinine normal Blood electrolytes Blood glucose decreased Blood lactic acid Blood urea increased COVID-19 Cardiomegaly Chest X-ray abnormal Computerised tomogram abdomen abnormal Condition aggravated Electrolyte substitution therapy Gastrointestinal haemorrhage Gastrointestinal wall thickening Haemoglobin normal Hypoglycaemia Melaena Occult blood positive

Symptomtext

Discharge Physician: MD, MPH Primary Care Physician: MD Date of Admission: 3/24/2023 Discharge Date: 3/26/2023 Room Number: PRESENTING PROBLEM: GI bleed [K92.2] Gastrointestinal hemorrhage with melena [K92.1] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 68 y.o. female who presents today with GI bleeding. She has a history of DM, fatty liver disease for which she previously saw Dr., HTN, PAD, COPD, Bipolar disorder, and adrenal mass s/p removal. In the ER today she tested positive for COVID. Hemoccult was positive. BUN mildly elevated at 26 with creatinine of 0.82. Initial glucose was 49. WBC 6.76, hgb 12.0, platelets 275, lactic acid 0.9, UA negative for infection. CXR showed cardiac enlargement with small right pleural effusion. CT of the abdomen/pelvis showed possible very mild colitis and possible mild cystitis. However, CTA abdomen and pelvis thought wall thickening was likely related to underdistention. She was given dextrose for hypoglycemia. She was given IV protonix, zofran, and IVF. She was placed in observation for GI bleeding. GI consulted and recommended PPI q12 and advancing diet as tolerated. Stool studies were negative. Outpatient EGD/colonoscopy was recommended due to COVID19 status. She received IV iron infusion and ASA/Plavix held, given no further bleeding. ASA/Plavix resumed without further bleeding noted. Electrolytes were monitored and repleted PRN throughout the admission. Patient clinically improved and hemodynamically stable for discharge. Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. . Patient voiced understanding was agreeable with plan of care discharge

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Dyslipidemia, goal LDL below 55 HTN (hypertension), benign Psoriasis Type 1 diabetes mellitus with diabetic neuropathy PAD (peripheral artery disease) Bipolar disorder, current episode mixed, unspecified Hypercholesterolemia Steatosis of liver Pulmonary emphysema Irritable bowel syndrome with diarrhea Chronic fatigue Requires assistance with activities of daily living (ADL) Type 1 diabetes mellitus with proliferative retinopathy of both eyes without macular edema Palpitations Murmur Stenosis of right carotid artery Pre-op exam GI bleed Diarrhea COVID-19
Andere Medikamente
acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler Alcohol Swabs (ALCOHOL WIPES) 70 % PADS ammonium lactate (LAC-HYDRIN) 12 % lotion aspirin 81 MG chewable tablet ben
Allergien
None
Vorherige Impfungen
-

VAERS 2517634

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj933aa

moderat
Staat
CA
Alter
85,0
Geschlecht
F
Eingang
30.11.2022
Impfdatum
21.11.2022
Beginn
22.11.2022
Tage bis Beginn
1,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Asthenia Injection site pain Injection site swelling Mobility decreased Joint swelling Pain

Symptomtext

Site: Pain at Injection Site-Medium, Site: Swelling at Injection Site-Severe, Systemic: Joint Pain-Severe, Systemic: Weakness-Severe, Additional Details: Pt reports swelling at site and cannot lift her arm

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2528642

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj933aa

mild
Staat
CA
Alter
65,0
Geschlecht
M
Eingang
12.12.2022
Impfdatum
02.11.2022
Beginn
02.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site pain Injection site swelling

Symptomtext

Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Additional Details: patient claimed to have experienced a large area of redness, swelling and pain around the site of injection (right arm) but says it has now cleared. no other issues reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2506713

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AA

mild
Staat
CA
Alter
65,0
Geschlecht
M
Eingang
13.11.2022
Impfdatum
03.11.2022
Beginn
03.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Chills Dizziness Fatigue Headache Injection site pain Lethargy Nausea Pain

Symptomtext

Site: Pain at Injection Site-Severe, Systemic: Body Aches Generalized-Medium, Systemic: Chills-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Headache-Severe, Systemic: Nausea-Severe, Systemic: Weakness-Severe

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2506601

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AA

mild
Staat
CA
Alter
66,0
Geschlecht
F
Eingang
12.11.2022
Impfdatum
02.11.2022
Beginn
03.11.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site bruising Injection site erythema Injection site pain Injection site swelling

Symptomtext

Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Medium, Additional Details: Patient does not have any range of motion problem just concerned about the bruising & swelling which is getting better still but there

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site bruising
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2505438

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj933aa

mild
Staat
CA
Alter
65,0
Geschlecht
F
Eingang
11.11.2022
Impfdatum
05.11.2022
Beginn
05.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site swelling

Symptomtext

Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: advised patient to use ice pack and take tylenol. and to follow up with a doctor if symptoms do not improve or persists

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2497684

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AA

mild
Staat
NJ
Alter
72,0
Geschlecht
F
Eingang
03.11.2022
Impfdatum
01.10.2022
Beginn
16.10.2022
Tage bis Beginn
15,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Hypoaesthesia oral Lip swelling Pain in extremity

Symptomtext

LIPS SWELLING AND NUMBNESS, ARM PAIN (PERSISTING 2 WEEKS AFTER ADMINISTRATION) ON RIGHT ARM (FLU)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NONE THAT SHE KNEW OF
Vorherige Impfungen
-

VAERS 2495093

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AA

mild
Staat
OH
Alter
71,0
Geschlecht
F
Eingang
01.11.2022
Impfdatum
27.10.2022
Beginn
27.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Body temperature increased Chills Ear pain Fatigue Headache Neck pain Pyrexia

Symptomtext

She got her vaccine, she felt fine until about 9:50 PM when she started to get chills, and then started to get really really chilled. She went to bed, covered up with all her blankets and then had fever, her neck started getting sore, ears were hurting and put a washrag on her head and headache no the back of her head. Took her temp and it was 102, and laid in bed as she was really cold and she was tired. By the next day her fever broke and she was feeling better and still very tired. On Sunday she was feeling better, and she is back to being normal today. She took Tylenol for her fever, which it was gone by the next day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
Cold in September.
Vorgeschichte
High blood pressure.
Andere Medikamente
Esomeprazole 40 mg, Losartan/potassium 50 mg.
Allergien
None.
Vorherige Impfungen
-

VAERS 2492272

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AA

mild
Staat
MI
Alter
67,0
Geschlecht
F
Eingang
28.10.2022
Impfdatum
20.10.2022
Beginn
20.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cellulitis Injection site erythema Injection site mass Injection site oedema Injection site pain Injection site pruritus Injection site warmth Pain Pain in extremity

Symptomtext

developed ++left arm soreness with pain 6/10 constant especially with movement non radiating night of 10/22/22 to left deltoid and noticed "golf bal"l size lump mid bicep brachi. + redness no streaking, + warmth, with edema. Urgent care 10/24/22 diagnosed with celluitis and treated with keflex 500 mg QID x 7 days Evaluated employee health 10/20/22 improvement in lump to upper left deltoid subsideing no further redness, no streaking, no warmth, no edema, slight tenderness if pushes on it, + itching, pain 0/10. full ROM. denies any SOB, CP, fatigue, chills, fever, muscle aches, dizziness, working full duties without difficulty as unit clerk. keflex completed 10/29/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2539461

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AA

gering
Staat
-
Alter
58,0
Geschlecht
F
Eingang
21.12.2022
Impfdatum
15.10.2022
Beginn
15.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age

Symptomtext

given to 58 y.o

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2517829

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj933aa

gering
Staat
OH
Alter
82,0
Geschlecht
F
Eingang
28.11.2022
Impfdatum
17.11.2022
Beginn
17.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered

Symptomtext

Patient received 2 doses of Fluzone HD on 9/8/22 and 11/17/22

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2508568

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AA

gering
Staat
TX
Alter
64,0
Geschlecht
M
Eingang
15.11.2022
Impfdatum
15.11.2022
Beginn
15.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect dose administered Product administered to patient of inappropriate age

Symptomtext

Administered high dose influenza vaccine for people over the age of 65 on 11/15/2022 to patient who is 64 years old .

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2503936

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AA

gering
Staat
CT
Alter
87,0
Geschlecht
F
Eingang
10.11.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error Wrong product administered

Symptomtext

flu vaccine administered instead of Covid vaccine with no reported AE; Initial information received on 27-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 87 years old female patient who experienced flu vaccine administered instead of covid vaccine with no reported ae while receiving vaccine influenza quadrival a-b high dose hv vaccine [fluzone high-dose quadrivalent]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included influenza vaccine rha 3v (baculovirus) (flublok) for Immunisation. On an unknown date, the patient received a dose of suspect influenza quadrival a-b high dose hv vaccine lot UJ933AA via unknown route in unknown administration site. On an unknown date the patient developed a non-serious flu vaccine administered instead of covid vaccine with no reported ae (wrong product administered) (unknown latency) following the administration of influenza quadrival a-b high dose hv vaccine. It was reported "Nurse reports that a patient received 2 different flu vaccines, 1 week apart. Nurse states that they had a vaccination clinic yesterday, and an 87 year-old woman received a FLUBLOK vaccine. This morning, that patient's daughter called. The woman had already received a FLUZONE HIGH-DOSE QUADRIVALENT last week, at the facility where she lives. The daughter stated that she had made the appointment at the vaccination clinic for a Covid vaccine, but when the patient's son-in-law brought her to the appointment, he misunderstood and requested the the Flublok instead". Action taken: not applicable. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was Unknown for the event flu vaccine administered instead of covid vaccine with no reported ae. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
FLUBLOK
Allergien
-
Vorherige Impfungen
-

VAERS 2486188

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ933AA

gering
Staat
MN
Alter
86,0
Geschlecht
F
Eingang
21.10.2022
Impfdatum
20.10.2022
Beginn
20.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

PATIENT RECEIVED TWO SETS OF IDENTICAL VACCINES. RECEIVED FLUZONE HD AND PFIZER BIVALENT ON 10/14/22; AND THEN AGAIN ON 10/20/22; WAS PART OF A VACCINE CLINIC HOSTED AT ASSISTED LIVING FACILITY. NO ADVERSE REACTION HAD BEEN REPORTED. PHARMACY REALIZED ERROR WHEN BILLING THE SHOTS FROM 10/20/22 AND NOTIFIED ASSISSTED LIVING FACILITY AND PATIENTS PRIMARY CARE PHYSICIAN.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
UNKNOWN
Vorgeschichte
UNKNOWN
Andere Medikamente
UNKNOWN
Allergien
NO KNOWN
Vorherige Impfungen
-